ArticleBMC cancer2022

Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS).

Vasileia Tsintari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.